Park, B., Jeon, H., Kim, Y., Kwon, H., Choi, G., Chi, S., . . . Kim, T. (2024). Polyamine and EIF5A hypusination downstream of c-Myc confers targeted therapy resistance in BRAF mutant melanoma. Molecular Cancer, 23(1), . https://doi.org/10.1186/s12943-024-02031-w
Chicago Style (17th ed.) CitationPark, Byung-Sun, Heeju Jeon, Yeonseo Kim, Haejin Kwon, Ga-Eun Choi, Sung-Gil Chi, Hyun-Mee Park, Hyunbeom Lee, and Tackhoon Kim. "Polyamine and EIF5A Hypusination Downstream of C-Myc Confers Targeted Therapy Resistance in BRAF Mutant Melanoma." Molecular Cancer 23, no. 1 (2024). https://doi.org/10.1186/s12943-024-02031-w.
MLA (9th ed.) CitationPark, Byung-Sun, et al. "Polyamine and EIF5A Hypusination Downstream of C-Myc Confers Targeted Therapy Resistance in BRAF Mutant Melanoma." Molecular Cancer, vol. 23, no. 1, 2024, https://doi.org/10.1186/s12943-024-02031-w.